April 01, 2026 08:37 am (IST)
IRDA approves appointment of Trevor Bull as MD & CEO of Aviva India
New Delhi, Mar 9 (IBNS): The Insurance Regulatory and Development Authority of India has approved the appointment of Trevor Bull as the Managing Director and Chief Executive Officer of Aviva Life Insurance Company India Ltd.
Speaking on the occasion, Bull said, “I am delighted to have been appointed as the MD & CEO of Aviva India. India continues to be one of the most exciting global insurance markets with significant unrealized potential. I am excited at the opportunity to work with the team in further strengthening the business as we enter the next phase of growth.”
Bull has more than 35 years of experience in the insurance industry across Asia and Europe. In his career span, he has held key leadership positions in Zurich Insurance Malaysia Berhad, The Philippine American Life & General Insurance Company, Tata AIG Life Insurance, AIG Life Korea, ALICO Tokyo and Lutine Assurance Services Limited, Birmingham, UK.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
PwC India announces leadership transition in Deals Business
Tue, Mar 31 2026
DBS Bank India launches relationship-led banking for 'India’s globally mobile, emerging affluent'
Tue, Mar 31 2026
Major expansion ahead: Govt clears 29 proposals under ECMS
Tue, Mar 31 2026
Over 7.83 crore enterprises registered on Udyam Registration Portal (URP), says Minister
Mon, Mar 30 2026
2026 economic crisis ahead? Robert Kiyosaki shares investment plan
Sat, Mar 28 2026
Larsen & Toubro drops 3% despite securing ₹2,500 crore orders
Fri, Mar 27 2026
